News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
686,662 Results
Type
Article (40245)
Company Profile (252)
Press Release (646165)
Section
Business (206030)
Career Advice (2093)
Deals (35772)
Drug Delivery (84)
Drug Development (81177)
Employer Resources (170)
FDA (16094)
Job Trends (14877)
News (347478)
Policy (32828)
Tag
Academia (2565)
Africa (743)
Alliances (49330)
Alzheimer's disease (1159)
Approvals (16014)
Arizona (176)
Artificial intelligence (70)
Asia (37610)
Australia (6142)
Bankruptcy (355)
Best Places to Work (11343)
Biosimilars (63)
Biotechnology (177)
C2C Services and Suppliers (79874)
California (1909)
Canada (941)
Cancer (500)
Career advice (1748)
Cell therapy (123)
China (153)
Clinical research (63610)
Collaboration (145)
Colorado (81)
Compensation (83)
Connecticut (76)
COVID-19 (2524)
Cystic fibrosis (73)
Data (318)
Diabetes (81)
Diagnostics (6011)
Drug pricing (65)
Earnings (84723)
Employer resources (145)
Europe (80598)
Events (108835)
Executive appointments (160)
FDA (16325)
Florida (268)
Funding (151)
Gene therapy (94)
GLP-1 (523)
Government (4386)
Healthcare (18796)
Hotbed/Location (484197)
Illinois (260)
Indiana (148)
Infectious disease (2554)
Inflammatory bowel disease (91)
Interviews (326)
IPO (16343)
Job creations (3663)
Job search strategy (1498)
Kansas (94)
Layoffs (397)
Legal (7953)
Lung cancer (112)
Manufacturing (95)
Maryland (401)
Massachusetts (1545)
Medical device (13134)
Medtech (13139)
Mergers & acquisitions (19300)
Metabolic disorders (254)
Michigan (124)
Minnesota (214)
Neuroscience (1314)
New Jersey (593)
New York (602)
NextGen Class of 2024 (6539)
Non-profit (4496)
North Carolina (607)
Northern California (836)
Obesity (151)
Ohio (107)
Opinion (178)
Patents (76)
Pennsylvania (586)
People (56763)
Phase I (19710)
Phase II (28006)
Phase III (20947)
Pipeline (113)
Postmarket research (2589)
Preclinical (8376)
Press Release (66)
Radiopharmaceuticals (237)
Rare diseases (130)
Real estate (5939)
Recruiting (65)
Regulatory (21414)
Research institute (2334)
Resumes & cover letters (358)
South America (1113)
Southern California (776)
Startups (3607)
Texas (242)
United States (8681)
Vaccines (489)
Washington State (253)
Weight loss (131)
Date
Today (64)
Last 7 days (613)
Last 30 days (2442)
Last 365 days (37290)
2024 (26466)
2023 (40355)
2022 (51465)
2021 (55994)
2020 (54433)
2019 (46949)
2018 (35378)
2017 (32492)
2016 (31930)
2015 (37950)
2014 (31729)
2013 (26779)
2012 (29009)
2011 (29674)
2010 (27736)
686,662 Results for "thermogenesis holdings inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
ThermoGenesis Holdings, Inc. reported financial and operating results for the third quarter ended September 30, 2023, and provided a corporate business update.
November 13, 2023
·
8 min read
Biotech Bay
ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference
ThermoGenesis Holdings, Inc. today announced that Chris Xu , Ph.D., Chief Executive Officer, will present a company overview on Wednesday, September 13, at 4:30 pm ET.
September 6, 2023
·
1 min read
Business
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the third quarter ended September 30, 2023, and provide a corporate strategic update on Thursday, November 13, 2023, after the close of trading.
November 8, 2023
·
3 min read
Business
ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update
ThermoGenesis Holdings, Inc., a market leader in automated cell processing tools and services in the cell and gene therapy field, reported financial and operating results for the second quarter ended June 30, 2023, and provided a corporate business update.
August 10, 2023
·
8 min read
Business
Medpace Holdings, Inc. to Report Second Quarter 2024 Financial Results on July 22, 2024
Medpace Holdings, Inc. announced that it will report its second quarter 2024 financial results after the market close on Monday, July 22, 2024.
June 26, 2024
·
1 min read
Business
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update
ThermoGenesis Holdings, Inc. announced that the Company will release its financial results for the second quarter ended June 30, 2023, and provide a corporate strategic update on Thursday, August 10, 2023, after the close of trading.
August 8, 2023
·
3 min read
Lophos Holdings Inc. Announces the Completion of Securities Purchase Agreement with ThreeD Capital Inc.
Lophos Holdings Inc. (CSE: MESC) (“Lophos” or the “Company”), a Canadian bioscience company focused on the cultivation and sale of Lophophora williamsii (“Peyote”) and ThreeD Capital Inc. (CSE: IDK) (OTCQB: IDKFF) (“ThreeD”), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, are pleased to announce the completion of its previously announced Securities Purchase Agreement (the “Agreement”).
June 20, 2024
·
4 min read
Policy
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 24
Dallas, Texas--(Newsfile Corp. - June 4, 2024) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) for Q1 2024.
June 4, 2024
·
1 min read
BioCapital
Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook
Senseonics Holdings, Inc., a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring systems for people with diabetes, announced business updates and provided its full year 2024 financial outlook.
June 21, 2024
·
5 min read
BioCapital
Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference
Senseonics Holdings, Inc., a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring systems for people with diabetes, announced plans to participate in the upcoming Sidoti Small Cap Conference, being held in virtually.
May 29, 2024
·
1 min read
1 of 68,667
Next